申请人:Ignyta, Inc.
公开号:US09120778B2
公开(公告)日:2015-09-01
The present application provides compounds of Formula I
or salt forms thereof, wherein Ra, Rb, Rc, Rd, D, W, R1a, R1b, R1c, Y, R3, X, E and G are as defined herein, compositions, methods of treatment and uses thereof.
本申请提供了I式化合物或其盐形式,其中Ra,Rb,Rc,Rd,D,W,R1a,R1b,R1c,Y,R3,X,E和G的定义如本文所述,以及其组合物,治疗方法和用途。